K2M Names Don O’Hearn as SVP of Sales in the Americas to Drive Continued Growth in Global Spine Market

LEESBURG, VA … December 13, 2011 –K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced the appointment of Don O’Hearn as Senior Vice President of Sales in the Americas, an important milestone in the company’s strategic plan to become a global leader in the spine market.

Don O’Hearn has more than 20 years of medical industry expertise with 17 of those in the medical device field across the U.S., Canada and Latin America. His medical device expertise includes sales and operational leadership positions at AGA Medical and Medtronic.

“It’s an incredible time to be joining K2M,” said Mr. O’Hearn. “Its rapidly growing product portfolio coupled with its continued global expansion is compelling, particularly at a time when many in the industry are really regrouping for the future.”

Mr. O’Hearn holds a Masters of Business Administration from the University of Chicago Graduate School of Business with a concentration in Finance and Marketing, a Master of Science in Biochemistry and Biophysics from Yale University, and a Bachelor of Science in Molecular Biology from the University of Wisconsin.

“Don brings incredible experience to our team and demonstrates our investment in rapidly expanding the global business,” stated Eric Major, K2M’s President and CEO. “He will provide leadership in the development of an exclusive sales organization, building a presence throughout the Americas. I’m excited to work with Don, who will undoubtedly play a significant role in helping K2M offer the best solutions for physicians and patients around the world.”

About K2M

K2M, Inc. is an innovative spinal device company committed to the research, development, and commercialization of simplified solutions for the treatment of complex spinal pathologies and minimally invasive procedures. The company is recognized as a worldwide leader in providing unique technologies for the treatment of deformity, degenerative, trauma, and tumor spinal patients. K2M’s complete portfolio of next generation products includes: spinal stabilization systems, minimally invasive systems, and other advancing technologies such as motion preservation, annular repair, and nucleus replacement. Additional information is available online at www.K2M.com.